Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

CROI 2026: Basic Science Highlights From the 2026 Conference on Retroviruses and Opportunistic Infections.

Topics in antiviral medicine·2026
Same author

Proof-of-concept of host attribution of antimicrobial resistance genes using wastewater Hi-C metagenome sequencing.

Journal of water and health·2026
Same author

Wastewater SARS-CoV-2 and COVID-19 Hospital Admission and Mortality - A Controlled Experimental Study.

medRxiv : the preprint server for health sciences·2026
Same author

CROI 2025: Summary of Basic Science Research in HIV.

Topics in antiviral medicine·2025
Same author

Long term assessment of SARS-CoV-2 in wastewater and the transition to evaluate additional viral targets.

The Science of the total environment·2025
Same author

An observational cohort study evaluating PrEP reach, engagement and persistence through a community-based mobile clinic in Miami-Dade County, Florida.

Journal of the International AIDS Society·2024

関連する実験動画

Updated: May 11, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
10:22

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

RNA干渉によるHIV-1複製の調節

Jean-Marc Jacque1, Karine Triques, Mario Stevenson

  • 1Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, Massachusetts 01605, USA.

Nature
|June 28, 2002
PubMed
まとめ

小型の干渉RNA (siRNA) は,ウイルスのRNAを標的にして退廃させることで,HIV-1の複製を効果的に阻害する. このRNA干渉メカニズムは,HIV-1ライフサイクルの重要なステップを防止し,潜在的な治療戦略を提供します.

科学分野:

  • 分子生物学は分子生物学である.
  • ウイルス学 ウイルス学 ウイルス学
  • 遺伝子サイレンシング

背景:

  • RNA干渉 (RNAi) は,遺伝子サイレンシングのための自然なプロセスです.
  • 小型の干渉RNA (siRNA) は,哺乳類の細胞でRNAiを誘発する.
  • HIV-1複製には,治療的介入に敏感な複雑なステップが含まれています.

研究 の 目的:

  • HIV-1複製を抑制する siRNA の有効性を調査する.
  • siRNAがHIV-1ゲノムの様々な領域をターゲットにできるかどうかを判断する.
  • HIV複製サイクルを調節する siRNA の可能性を評価する.

主な方法:

  • 合成およびプラズミド由来のsiRNA複合体を使用した.
  • HIV-1ゲノムの複数の領域に siRNA を標的とする.
  • 人間の細胞系とプライマリリンパ球における評価された阻害.

主要な成果:

  • HIV-1の早期および後期複製段階の有意な阻害を示した.
  • siRNAsによってゲノムHIV-1RNAの特定の劣化を示した.
  • ウイルスの補完的なDNA中介物質の形成を防ぐ.

さらに関連する動画

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

関連する実験動画

Last Updated: May 11, 2026

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
10:22

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

結論:

  • siRNAによるRNA干渉は,HIV-1感染を抑制する強力な戦略です.
  • 複製複合体内のゲノム性HIV-1RNAは,siRNA媒介による分解に敏感である.
  • siRNA技術は,新しい抗HIV治療の開発に有望である.